Millions of women worldwide live with endometriosis, which causes symptoms like pain and extreme tiredness and, if untreated, ...

On Friday 17th October, the European Society for Medical Oncology’s Annual Meeting 2025 kicked off, with the opening press ...

The results – presented at the ESMO cancer congress and simultaneously published in Annals of Oncology – come after seven ...

EVERSANA to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated ...

Merck KGaA has become the third pharma company to reach an agreement with the Trump administration to cut the cost of some of ...

Lila Sciences' already impressive $235 million first round financing has continued to build and has now closed at $350 ...

The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher ...

While the M&A emphasis is currently on life sciences, a business unit which sells products used in R&D and manufacturing ...

Moreover, innovations in LNP formulations have improved not only their targeting ability, but also their drug-loading ...

Activist investor Shah Capital has called on the board of directors at Novavax to put the company up for sale, citing a ...

Eli Lilly has built the case for its oral GLP-1 agonist orforglipron with two more phase 3 readouts, including new data ...

Interestingly, while only 16% of oncology researchers reported using AI in biomarker detection and assessment at the time of ...